CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 65 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2014. The put-call ratio across all filers is 5.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $8,338,000 | +28.0% | 87,300 | -9.9% | 0.08% | +38.6% |
| Q4 2014 | $6,515,000 | +24.6% | 96,900 | 0.0% | 0.06% | +29.5% |
| Q3 2014 | $5,229,000 | +21.4% | 96,900 | 0.0% | 0.04% | +29.4% |
| Q2 2014 | $4,309,000 | +28.0% | 96,900 | 0.0% | 0.03% | +17.2% |
| Q1 2014 | $3,367,000 | +20.4% | 96,900 | 0.0% | 0.03% | +26.1% |
| Q4 2013 | $2,796,000 | +190.9% | 96,900 | +194.5% | 0.02% | +187.5% |
| Q3 2013 | $961,000 | – | 32,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPQ Asia Capital Ltd | 287,277 | $35,760,000 | 28.32% |
| WARBURG PINCUS LLC | 6,674 | $830,780,000 | 13.45% |
| Ariose Capital Management Ltd | 238,841 | $27,689,000 | 7.56% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 12,600 | $1,568,000 | 4.48% |
| RUDMAN ERROL M | 37,001 | $4,606,000 | 3.72% |
| INDUS CAPITAL PARTNERS, LLC | 245,237 | $30,527,000 | 2.89% |
| Ativo Capital Management LLC | 93,784 | $11,674,000 | 2.70% |
| OBERWEIS ASSET MANAGEMENT INC/ | 63,305 | $7,880,000 | 2.27% |
| Point72 Hong Kong Ltd | 31,500 | $3,921,000 | 2.14% |
| Cormorant Asset Management, LP | 112,867 | $14,050,000 | 1.55% |